Trials / Unknown
UnknownNCT04960293
Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids
"Comparison of Pain After Uterine Artery Embolization Using Spherical Gelfoam or Tris-acryl Gelatin Microsphere in Patients With Symptomatic Fibroids: A Prospective, Randomized Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to compare pain after uterine artery embolization using spherical gelfoam or tris-acryl gelatin microsphere in patients with symptomatic fibroids
Detailed description
Uterine artery embolization(UAE) is a minimally invasive treatment alternative to hysterectomy and myomectomy in symptomatic fibroids. However, post-procedural pain after UAE remains a major problem. The spherical gelfoam and tri-acryl gelatin microsphere are two embolic materials used for UAE. Therefore, the aim of study is to compare pain intensity and inflammation after uterine artery embolization using the two embolic agents with symptomatic fibroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | uterine artery embolization using spherical gelfoam | Uterine artery embolization is performed using spherical gelfoam. All other processes are same. |
| PROCEDURE | uterine artery embolization using tri-acryl gelatin microsphere | Uterine artery embolization is performed using tris-acryl gelatin microsphere. All other processes are same. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
- First posted
- 2021-07-13
- Last updated
- 2021-07-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04960293. Inclusion in this directory is not an endorsement.